Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harshad Angel - New Portfolio
HARSHAD SOLANKI
Harshad AngelIndividual Investor
Ranked #424,681 out of 747,498 TipRanks' Investors
Success Rate
28 out of 62
profitable transactions
profitable transactions
Average Return
-2.99%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 7.08%
6-Month Return▲ 31.11%
12-Month Return-
YTD Return▲ 21.15%
Total Return▲ 34.70%
Best Trade
Bio
Managing my funds for maximum returns
Performance
25.65%0-25.65%
▲ 5.14%
▲ 4.57%
▲ 4.92%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 1.51%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 14.25%
Feb 2024
▲ 5.05%
▲ 3.27%
▼ 0.06%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 9.34%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 23.99%
May 2024
▼ 2.25%
▲ 3.53%
▼ 15.67%
Jun 2024
▲ 25.65%
▲ 0.88%
▲ 10.25%
Jul 2024
▲ 5.14%▲ 4.57%▲ 4.92%
▼ 1.87%▲ 1.59%▲ 1.51%
▲ 14.08%▲ 5.22%▲ 14.25%
▲ 5.05%▲ 3.27%▼ 0.06%
▼ 12.40%▼ 4.03%▼ 9.34%
▲ 11.46%▲ 5.06%▲ 23.99%
▼ 2.25%▲ 3.53%▼ 15.67%
▲ 25.65%▲ 0.88%▲ 10.25%
Recent Activity
Plug Power
11.54%
▼ 19.05%
11
Sell
Jul 19, 2024
Agenus
1.79%
▼ 55.18%
4
Buy
Jul 19, 2024
Advanced Micro Devices
2.02%
▼ 6.07%
5
Buy
Jul 19, 2024
Amazon
0%
▲ 6.77%
6
Sell
Jun 28, 2024
Nvidia
66.83%
▲ 22.53%
8
Buy
Jun 28, 2024
Alphabet Class A
0%
▲ 11.94%
7
Sell
Jun 28, 2024
Tesla
0%
▲ 39.47%
4
Sell
Jun 21, 2024
Atara Biotherapeutics
0.88%
▼ 30.18%
8
Buy
Jun 16, 2024
Meta Platforms
0%
▲ 14.30%
5
Buy
Jun 13, 2024
Fuelcell Energy
5.39%
▼ 46.90%
6
Buy
Jun 13, 2024
Taysha Gene Therapies
0.79%
▼ 9.90%
3
Sell
Jun 06, 2024
Sonnet BioTherapeutics Holdings
0.31%
▼ 52.11%
3
Sell
Jun 06, 2024
Costco
6.2%
▼ 0.54%
1
Open
Jun 06, 2024
BioCryst
2.11%
▲ 52.20%
5
Sell
May 17, 2024
Vuzix
0.1%
▼ 0.75%
3
Sell
May 17, 2024
Bitcoin
0%
▲ 12.78%
1
Open
May 01, 2024
Ethereum
0%
▲ 17.20%
1
Open
May 01, 2024
TScan Therapeutics
2.05%
▲ 35.84%
3
Sell
Apr 30, 2024
Alphabet Class C
―
▲ 17.71%
2
Close
Feb 18, 2024